AbbVie Inc.
TREATMENT OF NON-SMALL CELL LUNG CANCER
Last updated:
Abstract:
The present invention provides methods of treating non-small cell lung cancer in a patient comprising administering to the patient an effective amount of a PARP inhibitor, wherein the patient is Lung Subtyping Panel (LSP) positive.
Status:
Application
Type:
Utility
Filling date:
26 Jun 2018
Issue date:
30 Apr 2020